This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Muhid Bin Shahid, PhD
Senior Process Engineer, Chemical Development at AstraZeneca
Speaker

Profile

Muhid joined the Chemical Development department in Pharmaceutical Technology & Development at AstraZeneca in 2021 after completing PhD studies at University of Strathclyde. Since 2021, Muhid significantly contributed to oligonucleotide process development, with a focus on downstream processing, and have supported clinical drug substance manufactures for late-stage oligonucleotide projects.

Agenda Sessions

  • Streamlining Oligonucleotide Manufacture: Improving Efficiency and Sustainability via Implementation of Single Chromatography

    15:00